Literature DB >> 33579312

Expression of apoptosis repressor with caspase recruitment domain (ARC) in familial adenomatous polyposis (FAP) adenomas and its correlation with DNA mismatch repair proteins, p53, Bcl-2, COX-2 and beta-catenin.

Christoph Roser1,2, Csaba Tóth3,4, Marcus Renner3, Esther Herpel3,5, Peter Schirmacher3.   

Abstract

BACKGROUND: Colorectal familial adenomatous polyposis (FAP) adenomas exhibit a uniform pathogenetic basis caused by a germline mutation in the adenomatous polyposis gene (APC), but the molecular changes leading to their development are incompletely understood. However, dysregulated apoptosis is known to substantially affect the development of colonic adenomas. One of the key regulatory proteins involved in apoptosis is apoptosis repressor with caspase recruitment domain (ARC).
METHODS: The expression of nuclear and cytoplasmic ARC in 212 adenomas from 80 patients was analyzed by immunohistochemistry. We also compared expression levels of ARC with the expression levels of p53, Bcl-2, COX-2, and MMR proteins. Statistical analyses were performed by Spearman's rank correlation and linear regression test.
RESULTS: ARC was overexpressed in the nuclei and cytoplasm of most FAP adenomas investigated. Cytoplasmic ARC staining was moderately stronger (score 2) in 49.1% (n = 104/212) and substantially stronger (score 3) in 32.5% (n = 69/212) of adenomas compared to non-tumorous colorectal mucosa. In 18.4% (n = 39/212) of adenomas, cytoplasmic ARC staining was equivalent to that in non-tumorous mucosa. Nuclear expression of ARC in over 75% of cells was present in 30.7% (n = 65/212) of investigated adenomas, and nuclear expression in 10-75% of cells was detected in 62.7% (n = 133/212). ARC expression in under 10% of nuclei was found in 6.6% (n = 14/212) of adenomas. The correlation between nuclear ARC expression and cytoplasmic ARC expression was highly significant (p = 0.001). Moreover, nuclear ARC expression correlated positively with overexpression of Bcl-2, COX-2 p53 and β-catenin. Cytoplasmic ARC also correlated with overexpression of Bcl-2. Sporadic MMR deficiency was detected in very few FAP adenomas and showed no correlation with nuclear or cytoplasmic ARC.
CONCLUSIONS: Our results demonstrated that both cytoplasmic and nuclear ARC are overexpressed in FAP adenomas, thus in a homogenous collective. The highly significant correlation between nuclear ARC and nuclear β-catenin suggested that ARC might be regulated by β-catenin in FAP adenomas. Because of its further correlations with p53, Bcl-2, and COX-2, nuclear ARC might play a substantial role not only in carcinomas but also in precursor lesions. Video Abstract.

Entities:  

Keywords:  ARC; Apoptosis; Bcl-2; COX-2; FAP; Mismatch repair protein; p53; β-catenin

Mesh:

Substances:

Year:  2021        PMID: 33579312      PMCID: PMC7879509          DOI: 10.1186/s12964-020-00702-x

Source DB:  PubMed          Journal:  Cell Commun Signal        ISSN: 1478-811X            Impact factor:   5.712


  53 in total

Review 1.  Chemoprevention in familial adenomatous polyposis.

Authors:  Brian Kim; Francis M Giardiello
Journal:  Best Pract Res Clin Gastroenterol       Date:  2011-08       Impact factor: 3.043

2.  Microsatellite instability (MSI) increases with age in normal somatic cells.

Authors:  Mary I Coolbaugh-Murphy; Jingping Xu; Louis S Ramagli; Barry W Brown; Michael J Siciliano
Journal:  Mech Ageing Dev       Date:  2005-10       Impact factor: 5.432

3.  An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.

Authors:  Bing Z Carter; Po Yee Mak; Xiangmeng Wang; Wenjing Tao; Vivian Ruvolo; Duncan Mak; Hong Mu; Jared K Burks; Michael Andreeff
Journal:  Cancer Res       Date:  2019-01-23       Impact factor: 12.701

4.  BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.

Authors:  Naoko Tsuyama; Seiji Sakata; Satoko Baba; Yuko Mishima; Noriko Nishimura; Kyoko Ueda; Masahiro Yokoyama; Yasuhito Terui; Kiyohiko Hatake; Masanobu Kitagawa; Naoki Ishizuka; Naoto Tomita; Kengo Takeuchi
Journal:  Blood       Date:  2017-05-18       Impact factor: 22.113

5.  ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer.

Authors:  Isabelle Mercier; Magalis Vuolo; Jean-Francois Jasmin; Christina M Medina; Mark Williams; John M Mariadason; Hong Qian; Xiaonan Xue; Richard G Pestell; Michael P Lisanti; Richard N Kitsis
Journal:  Cell Cycle       Date:  2008-03-19       Impact factor: 4.534

6.  p53 Protein overexpression in colorectal tumors from patients with familial adenomatous polyposis: is it an early or late event?

Authors:  E Levi; S J Stryker; M S Rao
Journal:  Am J Gastroenterol       Date:  1996-01       Impact factor: 10.864

7.  Nuclear beta catenin as a potential prognostic and diagnostic marker in patients with colorectal cancer from Hong Kong.

Authors:  S C C Wong; E S F Lo; A K C Chan; K C Lee; W L Hsiao
Journal:  Mol Pathol       Date:  2003-12

8.  Nuclear translocation of beta-catenin in colorectal cancer.

Authors:  M Kobayashi; T Honma; Y Matsuda; Y Suzuki; R Narisawa; Y Ajioka; H Asakura
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

9.  Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.

Authors:  Isabel Sicking; Karlien Rommens; Marco J Battista; Daniel Böhm; Susanne Gebhard; Antje Lebrecht; Cristina Cotarelo; Gerald Hoffmann; Jan G Hengstler; Marcus Schmidt
Journal:  BMC Cancer       Date:  2014-12-15       Impact factor: 4.430

Review 10.  The Arc of synaptic memory.

Authors:  Clive R Bramham; Maria N Alme; Margarethe Bittins; Sjoukje D Kuipers; Rajeevkumar R Nair; Balagopal Pai; Debabrata Panja; Manja Schubert; Jonathan Soule; Adrian Tiron; Karin Wibrand
Journal:  Exp Brain Res       Date:  2009-08-19       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.